Blast Phase Myeloproliferative Neoplasm

general

Transformation of a myeloproliferative neoplasm into acute myeloid leukemia, typically via accelerated phase myeloproliferative neoplasm. Myeloblasts account for 20% or more of the peripheral blood white cells or the nucleated cells in the bone marrow.

23

Centers

31

Active Trials

$3.6B

Cancer Funding

Specific Cancer Types(1)

NameCenters
Chronic Myeloid Leukemia, Chronic Phase15

Top Centers for Blast Phase Myeloproliferative Neoplasm(23)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
55.0
2
NCI Comprehensive
Active Research Program
55.0
355.0
4
NCI Comprehensive
Active Research Program
55.0
5
NCI Comprehensive
Active Research Program
55.0
6
NCI Clinical
Active Research Program
55.0
7
NCI Comprehensive
Active Research Program
55.0
8
NCI Comprehensive
Active Research Program
55.0
9
Active Research Program
55.0
10
Active Research Program
55.0
11
NCI Comprehensive
12
13
NCI Comprehensive
14
NCI Comprehensive
15
NCI Comprehensive
16
NCI Comprehensive
17
NCI Comprehensive
18
NCI Comprehensive
19
20
21
NCI Comprehensive
22
23

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →